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Abstract
Background: Moderate hypothermia after decompressive surgery might not be beneficial for stroke patients. However,
normothermia may prove to be an effective method of enhancing neurological outcomes. The study aims were to
evaluate the application of a pre-specified normothermia protocol in stroke patients after decompressive surgery and its
impact on temperature load, and to describe the functional outcome of patients at 12 months after treatment.
Methods: We analysed patients with space-occupying middle cerebral artery (MCA) infarction treated with
decompressive surgery and a pre-specified temperature management protocol. Patients treated primarily with
device-controlled normothermia or hypothermia were excluded. The individual temperature load above 36.5 °C
was calculated for the first 96 h after hemicraniectomy as the Area Under the Curve, using °C x hours. The effect
of temperature load on functional outcome at 12 months was analysed by logistic regression.
Results: We included 40 stroke patients treated with decompressive surgery (mean [SD] age: 58.9 [10.1] years;
mean [SD] time to surgery: 30.5 [16.7] hours). Fever (temperature > 37.5 °C) developed in 26 patients during the first
96 h after surgery and mean (SD) temperature load above 36.5 °C in this time period was 62,3 (+/− 47,6) °C*hours. At
one year after stroke onset, a moderate to moderately severe disability (modified Rankin Scale score of 3 or 4) was
observed in 32% of patients, and a severe disability (score of 5) in 37% of patients, respectively. The lethality in the
cohort at 12 months was 32%. The temperature load during the first 96 h was not an independent predictor for
12 month lethality (OR 0.986 [95%-CI:0.967–1.002]; p < 0.12).
Conclusions: Temperature control in surgically treated patients with space-occupying MCA infarction using a
pre-specified protocol excluding temperature management systems resulted in mild hyperthermia between 36.8 °C
and 37.2 °C and a low overall temperature load. Future prospective studies on larger cohorts comparing different
strategies for normothermia treatment including temperature management devices are needed.
Keywords: Stroke, Space-occupying infarction, Decompressive surgery, Hemicraniectomy, Temperature management,
Normothermia
Background
Early decompressive hemicraniectomy can increase sur-
vival and improve functional outcome in patients with
space-occupying middle cerebral artery (MCA) infarc-
tion [1–3]. The swelling of infarcted brain tissue reaches
its maximum between day 2 and 5 after stroke onset [4].
Infarction edema leading to cerebral herniation is the
main cause of early, intra-hospital deaths in surgically
treated patients [2, 3]. Conservative treatment options,
e.g. osmotherapy or deep sedation with barbiturates, are
used to treat infarction edema, although data from ran-
domized trials supporting their use are lacking [5].
Fever occurs in about half of all stroke patients and is
associated with worse functional outcome of affected pa-
tients [6, 7]. Fever control and treatment of the under-
lying causes are well-established parts of routine clinical
practice, but sufficient data are lacking to support the
use or the type and timing of fever control in stroke
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patients [8, 9]. Temperature management can include an-
tipyretics (e.g. acetaminophen, metamizole), physical ap-
plications (e.g. wet blankets), and the use of temperature
management systems (TMS), either as endovascular or
body surface devices [10].
Normothermia in patients with space-occupying infarc-
tion, especially within the first five days after hemicra-
niectomy, could avoid brain volume increase and critical
rise of intracranial pressure that might be associated with
elevated body temperature. However, there are no conclu-
sive studies that demonstrate that normothermia is associ-
ated with improved functional outcomes in these patients.
Controlled moderate hypothermia, with target tem-
peratures between 33 °C and 35 °C, has been evaluated
as a treatment option for ischemic stroke including
space-occupying infarction [11–16]. Recent studies in-
cluding a randomized controlled trial suggest that
hypothermia in addition to hemicraniectomy might not
be beneficial for patients with malignant MCA infarc-
tion, partially due to a higher rate of adverse events in
cooled patients [17, 18].
Controlled normothermia to prevent fever was suggested
as a promising approach to improve functional outcome
compared to strategies that are reactive to temperature ele-
vations. Detailed data on temperature course of surgically
treated stroke patients managed with “reactive” normo-
thermia protocols are not available. This limits the ability
to calculate e.g. the sample sizes for randomized trials
comparing normothermia strategies [19].
The aims of our study are therefore: 1) to describe in
detail the individual temperature course and temperature
load above 36.5 °C in stroke patients during the first 96 h
after hemicraniectomy, using a pre-specified normother-
mia protocol excluding temperature management systems,
and 2) to evaluate the functional outcome at 12 months
after treatment.
Methods
Study design
This is a retrospective observational cohort study. Func-
tional outcome at 6 and 12 months was assessed prospect-
ively by structured telephone interviews: 1) for patients
included in our local registry for space-occupying MCA
infarction of older patients (age < 60 years), and 2) for pa-
tients that were included in randomized trials at our cen-
ter (1 and 2: n = 26). For the remaining patients (n = 14),
we evaluated functional outcome using hospital and re-
habilitation reports stating the modified Rankin Scale
score, and / or by a structured telephone interview to
retrospectively assess the modified Rankin Scale score if
hospital and rehabilitation reports were insufficient. Func-
tional outcome was assessed for all patients of the cohort
by study personal or investigators not involved in patient
care and before study specific data analyses were
performed.
Patient selection
We identified stroke patients treated with hemicraniect-
omy between November 2011 and June 2016, searching:
a) our research registry that includes patients over
60 years old with space-occupying MCA infarction and
hemicraniectomy (n = 15), b) local patient logs of com-
pleted randomized trials of hemicraniectomy (DESTINY
II, n = 3; DEPTH-SOS, n = 8), and c) our electronic hos-
pital information system (n = 14).
The inclusion criteria were: a) space-occupying ischemic
infarction in the MCA territory, b) hemicraniectomy, c)
temperature management according to our pre-specified
protocol (below) and d) no treatment with temperature
management systems to induce normothermia or
hypothermia.
Stroke treatment and intensive care
Patients were treated according to current European
stroke guidelines. Stroke treatment included systemic
thrombolysis and/or endovascular therapy if indicated by
the treating physician. According to our institutional
standard for treatment of space-occupying infarction, de-
compressive surgery should be performed within 48 h
after stroke onset (or time of last seen well), if the follow-
ing criteria have been fulfilled: a) clinical signs of MCA in-
farction, b) infarction >2/3 of the MCA territory, detected
on cerebral CT or MRI, c) NIHSS >15 (non-dominant
hemisphere) or NIHSS >20 (dominant hemisphere), and
d) reduced level of consciousness. Postoperatively, patients
were transferred sedated, intubated, and mechanically
ventilated to our ICU. Neuromonitoring included intra-
cranial pressure (ICP) monitoring using an ipsilaterally
inserted ICP probe. A cerebral CT was performed 24 (12–
36) hours after hemicraniectomy. Patients with progres-
sive edema were maintained deeply sedated (midazolame,
propofol) and received osmotherapy with mannitol if ICP
was elevated above 15 mmHg. Furthermore, the cerebral
perfusion threshold was defined as 70 mmHg. ICP rescue
interventions were osmotherapy with hypertonic sodium
solutions and barbiturate sedation.
Pre-specified temperature management protocol
Normothermia was defined as a body core temperature
of 36.5 °C, measured by a bladder catheter. Temperature
was measured continuously and documented automatic-
ally every hour in the electronic patient management
system. Hyperthermia >37.5 °C was treated primarily
with acetaminophene as a short infusion (1 g). Patients with
persistent hyperthermia after 2 h received further acetami-
nophene infusions (maximum 4 g/d). Non-responders to
acetaminophene received metamizole as a short infusion
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(1 g) and/or cold water wrappers on their arms, trunk
and legs.
Infection monitoring consisted of a daily clinical evalu-
ation; daily laboratory testing of blood count, C-reactive
protein, and/or procalcitonin; and a chest X-ray every
second day for ventilated patients. Further diagnostic
procedures to evaluate infections (e.g., urine analysis,
cultures, ultrasound, CT) were performed if local or sys-
temic signs of infections were present. Antibiotic therapy
was applied according to our institutional standard if
indicated.
Data management
Data on baseline patient characteristics and hospital treat-
ment were retrieved from electronic patient files (ICM®,
Dräger; ORBIS®, Agfa). Vital paramaters including body
core temperature were measured continuously and
transferred hourly to electronic patient files (ICM®, Dräger).
Individual temperature data were retrieved as electronic
files for analysis and stored electronically. All data were
checked for completeness and consistency by two
investigators.
Temperature load
Mean time from symptom onset to hemicraniectomy
was expected to be between 24 and 36 h. We selected an
evaluation period of 96 h postoperatively to fully cover
the critical phase of brain edema, usually observed be-
tween days 2 and 5 after infarction.
Temperature load (TL) was defined as the sum of the
products of body temperature above the temperature
level of 36.5 °C (defined as normothermia) and time (°C
* hours), calculated for each hour during the postopera-
tive 96 h. TL therefore corresponds to the area under
the temperature curve above a temperature of 36.5 °C.
The TL for each patient was calculated in two steps by the
following formulas (condition: ti > 0) (t = temperature;
h = hours; TL = temperature load) (11):
ti
 ¼ ti þ tiþ1
2
−36:5 ð1Þ
TL ¼
X96
i¼1ti
 1h ð2Þ
For subgroup analyses we calculated the median
temperature load above the temperature level of 36.5 °C
of the cohort and divided the cohort into two patient
groups, 1) low temperature load and 2) high temperature
load, according to the median TL.
The temperature load above the temperature level of
37.5 °C was calculated accordingly for each patient for
the first 96 h after decompressive surgery.
Statistical analysis
We calculated frequencies, means with standard deviations
(SD), and median values with inter-quartile ranges (IQR)
for the whole cohort and two subgroups. The two sub-
groups were defined according to the median temperature
load of the cohort (low temperature load group [n = 20]
and high temperature load group [n = 20]). Student’s t-test
was used for normally distributed data; the Mann-Whitney
U test was used for skewed continuous data and ordinal
data; and Fischer’s exact test was used for categorical data.
Univariate regression analyses were performed to evalu-
ate the impact of clinically relevant patient and treatment
characteristics, including temperature load and temperature
deviation, on mortality at 12 months. Explorative
multivariate regression analyses with 3 factors were
calculated, including the factors temperature load
(metric or dichotomized according to the median
temperature load of the cohort), temperature deviation,
age, sex, affected hemisphere, stroke severity (NIHSS),
or diameter of hemicraniectomy. Hosmer-Lemeshow
tests were performed for all models.
We used the software packages SPSS, version 23
(IBM Corp.; USA), and R, version 3.2.3 (R Foundation;
http://www.r-project.org/), for statistical analyses.
Ethical statement
The study was approved by our institutional review board
(Ethikkommission an der TU Dresden; IRB00001473;
EK125042012, EK204062013).
Informed consent
Due to the retrospective study design, no informed consent
was needed to include patients in the study. An informed
consent was obtained from patients or their legal represen-
tatives, if functional outcome was evaluated retrospectively
by a structured telephone interview.
Results
Patient cohort: Characteristics, treatment, and functional
outcome
The study cohort consisted of 40 patients with space-
occupying MCA infarction treated with decompressive
surgery. Table 1 shows baseline and treatment character-
istics of the patients. Mean patient age was 58.9 years
and mean time to surgery was 30.5 h (median 29.50
[IQR 18.5–35] hours). Thirty patients of the cohort were
transferred from rural hospitals to the stroke centre (e.g.
for endovascular therapy, decompressive surgery).
Postoperative mean body temperature course of the
cohort is illustrated in Fig. 1, presenting the first 96 h
after hemicraniectomy. Patients left the operating room
mildly hypothermic and with a slightly lower body
temperature compared to the pre-operative temperature.
After transfer to the ICU, patients showed a moderate
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temperature rise within 24 h, peaking between 37.0 °C
and 37.5 °C. In the following time period, body
temperature remained widely stable between 36.8 °C and
37.2 °C. Individual temperature courses of patients with
lowest and highest temperature deviations are presented
in Additional file 1: Figure S1.
A body temperature above 37.5 °C was observed in 26
of 40 patients during the observation period. Mean
temperature load above 37.5 °C in the cohort was
14.3 °C * hours during the first 96 h after hemicra-
niectomy. Severe fever above 39.0 °C was seen in only one
patient and present for less than 2 h. Antipyretics were
given to 34 patients; in 8 of these 34 patients, antipyretic
drugs were given at body temperatures below 37.5 °C
(36.7 °C – 37.4 °C). Fourteen patients received one antipyr-
etic, and 20 patients received two antipyretics. The mean
dose of acetaminophene, used as the first-line antipyretic,
was 2.95 g during the 96-h-period. A leucocytosis was de-
tected in 36 patients, and all patients received antibiotic
therapy at some time during the observational period.
Intrahospital lethality of the cohort was 18% by 6 months
and 32% by 12 months. Functional outcome according to
the modified Rankin scale (mRS) score at 12 months is
shown Fig. 2. For two patients of the high TL group, long
term functional outcome could not be assessed.
Comparison: Patients with low temperature load vs. high
temperature load
We grouped patients according to their temperature
load above 36.5 °C (area under curve, AUC; °C * hours),
calculated for postoperative 96 h, into low TL and high
TL patients using the median temperature load as the
cut-off (n = 20 patients in each group). The low TL
group had a mean temperature load of 20 (±19.2)°C*hr
compared to 104.6(±22.4) °C*hr in the high TL group
(p < 0.001).
Baseline and treatment characteristics of both patient
groups are presented in Table 1. Cardiovascular risk fac-
tors were observed in comparable frequencies in both
groups. Stroke severity on admission was slightly lower
Table 1 Baseline and treatment characteristics
All patients (n = 40) Low temperature load
patients (n = 20)
High temperature load
patients (n = 20)
p value
Age, years, mean (SD) 58.9 ± 10.1 59.0 ± 10.6 58.9 ± 9.9 0.976
Sex (female), n (%) 19 (47.5) 10 (50.0) 9 (45.0) >0.99
Arterial hypertension, n (%) 25 [62.5] 13 [65) 12 [60] >0.99
Hyperlipidemia, n (%) 11 [27.5] 7 [35] 4 [20] 0.480
Diabetes mellitus, n (%) 14 [35] 7 [35] 7 [35] 1.0
Atrial fibrillation, n (%) 10 [25] 5 [25] 5 [25] 1.0
Transfer from rural hospital to stroke center, n (%) 30 [75] 16 [80] 14 [70] 0.716
NIHSS score (admission), median (IQR) 32 [20–32] 28 (20.25–32) 32 (18–32) 0.695
Dominant hemisphere, n (%) 22 (55.0) 14 (70.0) 8 (40.0) 0.111
Intravenous rtPA, n (%) 20 [50] 7 [35] 13 [65] 0.113
Endovascular therapy, n (%) 8 [20] 2 [10] 6 [30] 0.235
Symptom onset to hemicraniectomy, h, mean (SD) 30.5 (16.7) 31.6 (22.2) 29.4 (10.3) 0.695
Diameter of hemicraniectomy, cm, median (IQR) 12.9 (12.1–13.4) 13.0 (12.1–13.5] 12.8 (12.0–13.3) 0.867
Period of 96 h after surgery
Leucocytosis, n (%) 36 (90) 17 (85) 19 (95) 0.605
Antibiotics, n (%) 40 (100) 20 (100) 20 (100) NA
Antipyretics, n (%) 35 (87.5) 15 (75) 20 (100) 0.024
One antipyretic, n (%) 15 (37.5) 8 (40) 7 (35)
Two antipyretics, n (%) 20 (50) 7 (35) 13 (65)
Acetaminophen, g, mean (SD) 2.95 (2.2) 2.4 (2.5) 3.5 (1.8) 0.044
Metamizole, g, mean (SD) 1.38 (1.9) 1.05 (1.85) 1.7 (2) 0.132
Temperature load 96 h, >36.5 °C; °C x h, mean (SD) 62.3 (47.6) 20 (19.2) 104.6 (22.4) < 0.001
Temperature load 96 h, >37.5 °C; °C x h, mean (SD) 14.3 (15.4) 3.8 (7.3) 24.68 (14.4) < 0.001
Patients with T > 37.5 °C, n (%) 26 (65) 12 (60) 14 (70) 0.741
T temperature, SD standard deviation, NA not applicable
All p values in italics are below 0.05
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in the low TL group compared to the high TL group
(median NIHSS score 28 vs. 32). The dominant hemi-
sphere was affected more frequently in patients of the
low TL group compared to the high TL group (70% vs.
40%). Patients with high TL had received intravenous rtPA
and/or endovascular therapy more frequently compared
to patients with low TL. The median diameter of hemi-
craniectomy was comparable in the two groups (low TL
group: 13.0 cm vs. high TL group: 12.8 cm).
Mean body temperature courses of both groups are
depicted in Fig. 1. Preoperative temperatures did not dif-
fer in the two groups. In the low TL group, a mostly
normothermic course around 36.5 °C was observed
during the 96 h period. Patients in the high TL group
showed a temperature increase of about 1.5 °C within
the first 24 h after hemicraniectomy and remained
mildly to moderately hypertherm between 37.5 °C and
38.0 °C thereafter.
Treatment of hyperthermia with antipyretics was per-
formed more often in the high TL group, and accord-
ingly, the mean acetaminophene dose was higher in this
group (low TL 2.4 g vs. high TL 3.5 g). All patients re-
ceived antibiotic therapy. The length of the hospital stay
was comparable in both groups.
The hospital mortality was not statistically significant
different between the low TL and the high TL groups
(30% vs. 5%; p = 0.09, Fisher’s exact test). (Table 2). The
long-term functional outcome at 12 months after hemi-
craniectomy (Fig. 2) was not different in the two groups:
mRS score 0–3: low TL 20% vs. high TL 5.6% (p = 0.34);
mRS score 0–4: low TL 35% vs. high TL 27.8% (p = 0.74);
The case fatality rate at 12 months was 40% in the low TL
group and 22% in the high TL group (p = 0.31).
Impact of temperature load and other factors on lethality
at 12 months
The univariate logistic regression analysis revealed that
the temperature load during the first 96 h after hemicra-
niectomy had no significant effect on 12 months lethality
the cohort (OR 0.988 [95%-CI: 0.971–1.003]; p = 0.14). A
clinical more meaningful increase of the temperature
load of 10 °C*hours showed a comparable trend for
lower case fatality rate (OR 0.884[95%-CI 0.742–1.032];
p = 0.13). A higher temperature deviation did also not
increase the risk for lethality at 12 months (Table 3).
Factors associated with a statistically significant higher
risk for patients to decease within 12 months after stroke
onset were higher patient age, the affection of the
Fig. 1 Body temperature course within 96 h after hemicraniectomy.
Mean body temperature of the entire cohort (All), the low
temperature load (Low TL) group, and the high temperature load
(High TL) group, calculated for the pre-operative temperature and
each hour postoperatively within the observational period
Fig. 2 Functional outcome at 12 months on the modified Rankin Scale (mRS). mRS 0: no symptoms; mRS 1: no significant disability; mRS 2: slight
disability and inability to carry out all pre-stroke activities; mRS 3: moderate disability, but being able to walk without personal assistance or a
wheelchair; mRS 4: moderate to severe disability; needs assistance to attend to own bodily needs; unable to walk without assistance; mRS 5: severe
disability; requires constant attention and care; bedridden; mRS 6: death
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dominant hemisphere, and a shorter duration form stroke
onset to decompressive surgery, respectively.
Explorative multivariate regression modelling showed
that the factors temperature load and temperature devi-
ation, included with the factor age in the final model,
did not significantly impact the probability for death at
12 months (temperature load: OR 0.986 [95%-CI: 0.967–
1.002], p = 0.12; temperature deviation: OR 5.483 [95%-
CI:0.072–478.958], p = 0.44; age: OR 1.116[1.020–1.262],
p = 0.04; Hosmer-Lemeshow Test: C = 5.95; p = 0.65).
Discussion
Decompressive surgery is an effective treatment for pa-
tients with space-occupying MCA infarction, but still a
third of surgically treated patients die within 12 months,
mainly during the intra-hospital treatment phase. Inten-
sive care measures to reduce early lethality after decom-
pressive surgery include body temperature management,
but treatment strategies vary between centers.
In our single-center study, we analysed 40 stroke pa-
tients with hemicraniectomy, treated with normother-
mia according to a pre-specified temperature management
protocol based on antipyretics and physical measures. This
treatment strategy resulted in a low mean temperature load
above 36.5 °C within the 96 h observational period after
hemicraniectomy. Temperature load and temperature devi-
ation were not predictive for 12 months lethality in our
cohort.
Therapeutic hypothermia has been suggested as treat-
ment option for space-occupying MCA infarction and
was applied in several centers during the last 20 years,
mainly in addition to decompressive surgery. Recent stud-
ies showed conflicting results for hypothermia in surgi-
cally treated stroke patients. In a small randomized trial
with 33 patients, hypothermia (33 °C–34 °C) did not re-
duce mortality but survivors showed more often a better
functional outcome if they were treated with hypothermia.
A larger randomized controlled trial (DEPTH-SOS) was
terminated for safety reasons and showed no reduction of
early mortality in patients treated with hypothermia
(33 °C–34 °C) compared to patients treated with standard
care after decompressive surgery, but showed a higher rate
of severe adverse events at 12 months (77% vs. 42%) [18].
Furthermore, no beneficial effects of hypothermia were
found in a study evaluating treatment outcomes of a sin-
gle-center cohort (hypothermia treatment [33 °C–34 °
C] additionally to decompressive surgery) compared
with outcomes of patients of randomized hemicraniect-
omy trials (standard treatment additionally to decom-
pressive surgery) [17].
Maintaining normothermia after decompressive surgery
was suggested as an alternative treatment goal to further
reduce lethality in patients with space-occupying infarction
[19]. Normothermia can be achieved either by prophylactic
normothermia, e.g. with temperature management sys-
tems, or by reactive temperature management strategies.
In our single-center cohort, a reactive strategy was used
to achieve normothermia, excluding patients treated
with temperature management systems.
The baseline characteristics of the cohort were compar-
able with the characteristics of hemicraniectomy trial sam-
ples, including stroke severity, involvement of the dominant
hemisphere, and time to surgery. Median time to surgery
was 29.5 h our single-center cohort, compared with 20.5 to
41 h in recent randomized controlled trials [2, 3, 20, 21].
Mean pre-operative body temperature was 36.6 °C in our
cohort and 36.9 °C in the hemicraniectomy cohort of the
pooled analysis by Vahedi et al. [1].
Table 2 Mortality and functional outcome
All patients (n = 40) Low temperature load patients (n = 20) High temperature load patients (n = 20) p value
Lethality, in-hospital, n (%) 7 (17.5) 6 (30) 1 (5) 0.09
Lethality at 12 months, n (%) 12 (31.6)* 8 (40) 4 (22.2)** 0.31
mRS 0–3 at 12 months, n (%) 5 (13.2)* 4 (20) 1 (5.6)** 0.34
mRS 0–4 at 12 months, n (%) 12 (31.6)* 7 (35) 5 (27.8)** 0.74
T temperature, SD standard deviation, mRS modified Rankin Scale. *n = 38, **n = 18
Table 3 Univariate regression analyses. Odds ratios for 12 months mortality
Odds ratio 95%-CI p value
Patient age 1.098 1.013–1.215 0.022
NIHSS score 0.994 0.899–1.101 0.903
Dominant hemisphere 6.818 1.437–50.512 0.014
Time to decompressive surgery 0.925 0.844–0.991 0.022
Temperature load (96 h, >36.5 °C; °C x hours) 0.988 0.971–1.003 0.122
Temperature deviation (96 h) 1.820 0.037–81.408 0.755
All p values in italics are below 0.05
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Postoperative mean temperature course in our cohort
was characterized by a minimal postoperative temperature
decline from pre-operative normothermia observed in
most patients. This was followed by a moderate rise to a
maximum of the mean temperature of about 37.2 °C
within 24 h, and mild hyperthermia between 36.8 °C and
37.2 °C for the remaining observation period. Individual
doses of acetaminophene used for temperature control
were below the maximum daily dose permitted. Dual
antipyretic therapy was applied in half the patients, and
additional metamizole was applied in low doses. This
implicates that in our cohort body temperatures below
37.5 °C were achieved for most patients during the
post-operative observation period with relatively low
doses of antipyretics.
Intrahospital lethality was 17% in our cohort, which is
comparable to the data for ICU patients with ischemic
stroke (18%) from an earlier large case series [22]. The
long-term fatality rate in our cohort, including patients
up to 80 years old, was 31.1% at 12 months. This is com-
parable to the results of previous controlled trials with
mortality rates of 21% and 43% at 12 months [2, 3].
Temperature load >36.5 °C and temperature deviation
within 96 h after hemicraniectomy were no independent
predictors of long term mortality in our cohort. This can
be explained in part by the low overall temperature load
and the low to moderate temperature deviations observed.
Due to the sample size, other factors potentially influencing
mortality, e.g. infection rates or use of antibiotics, were not
tested by multivariate analyses. Early infection rates and
infection-related parameters such as leucocytosis were not
often reported in recent trials for hemicraniectomy. In the
DECIMAL cohort, 25% of patients had pneumonia and
10% had a urinary tract infection during the first week. In a
large cohort of neurocritical care patients, infection rates
(pneumonia, urinary tract infection) ranged from 13% to
33% [22]. Many patients with space-occupying stroke
develop dysphagia and a reduced level of consciousness,
leading to a high risk of aspiration despite prophylactic
measures like body positioning and fasting. The high
rate of early antibiotic use in our cohort implies a lower
therapeutic threshold in these stroke patients, partially
due to observed clinical signs of respiratory infection
and signs of systemic inflammation (leukocytosis [90%
of patients] and/or fever [65% of patients]).
An alternative to reactive normothermia manage-
ment is the application of prophylactic normothermia,
e.g. by endovascular or surface TMS. With the use of
TMS devices a defined target temperature (including
normothermia) can constantly achieved without rele-
vant temperature deviations [23–25]. As temperature
deviations in space-occupying infarction can lead to
clinical relevant volume effects known as rebound
phenomenon, this might be an important advantage of
prophylactic normothermia using TMS compared to re-
active temperature management strategies. On the other
hand, the use of endovascular TMS can be associated with
local or systemic infections or thrombosis, and body sur-
face TMS can induce skin irritations.
Randomized controlled trials in patients with space-
occupying infarction comparing a reactive normother-
mia management with prophylactic normothermia using
TMS are lacking. Recently, the Impact of Fever Preven-
tion in Brain Injured Patients (INTREPID) trial was ini-
tiated to asses the impact of fever prevention on fever
burden and neurologic outcomes in stroke patients
(ClinicalTrials.gov Identifier: NCT02996266). The fever
prevention group in this trial will be treated by a body
surface TMS and will be compared to patients treated
according to a step-wise fever management algorithm,
consisting primarily of intermittent antipyretics and cooling
blankets. This algorithm is comparable to the temperature
management protocol used in our cohort, which led to
a mean temperature between 36.8 °C and 37.2 °C.
Given the relatively small temperature difference be-
tween this observed mean temperature and a potential
target temperature between 36.0 °C or 37.0 °C for
prophylactic TMS normothermia, a randomized trial in
patients with space-occupying MCA infarction would
probably need a comparable large sample size like the
INTREPID trial (n = 1176) to detect a possible, clinically
meaningful difference between the two treatment strategies.
Furthermore, other aspects of temperature management
deserve attention in future studies, e.g. the definition of
normothermia, the threshold of fever, the duration of
targeted temperature management, or the adverse effects
of antipyretic treatments [26].
Our study has several strengths and limitations. We
addressed our question analysing a well characterized
cohort of patients with space-occupying MCA infarction
treated with hemicraniectomy. Although reflecting prac-
tice outside clinical trials, the observed generally low
temperature load above 36.5 °C suggests that temperature
management with a simple protocol is feasible in clinical
routine and that temperature management systems might
be needed only in selected patients. Our data might there-
fore be used to estimate the sample sizes needed for future
randomized trials comparing different temperature man-
agement strategies after decompressive surgery.
Given the design as an observational study, we did not
compare temperature management strategies or protocols.
The observed partial non-adherence to the normothermia
protocol, e.g. use of antipyretic drugs in some patients
below the pre-specified temperature level of 37.5 °C, is
mainly attributable to its use in daily clinical routine.
Another important limitation is the small number of
patients analysed, which limits the possibility to identify
associations of relevant variables with clinical outcomes.
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We evaluated only a limited number of factors relevant
for the functional outcome of stroke ICU patients. Fur-
thermore, we did not include safety measures in our ana-
lyses: antipyretics can be associated with hepatic and renal
toxicity and increase the risk of bleeding [27, 28].
Conclusions
Temperature management in stroke patients after de-
compressive surgery to achieve normothermia using a
pre-specified protocol resulted in mild hyperthermia be-
tween 36.8 °C and 37.2 °C and a low overall temperature
load. Functional outcome and mortality in our cohort at
12 months were comparable to outcomes reported for
surgically treated patients of randomized hemicraniect-
omy trials.
Temperature load and temperature deviation were not
independently predictive for long term mortality in our
cohort of 40 stroke patients who underwent decompressive
surgery. Future prospective studies on larger cohorts
comparing different strategies for normothermia, includ-
ing temperature management systems, are needed.
Additional file
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